Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cyclezyme ABXSAT:CYCLE -2.05%8 Gross Margin % is 0.00% as of Mar. 2026. GuruFocus rates XSAT:CYCLE with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 1,557 Chemicals companies, Cyclezyme AB ranks better than 99.87% on this metric.
The historical rank and industry rank for Cyclezyme AB's Gross Margin % or its related term are showing as below:
XSAT:CYCLE'
s Gross Margin % Range Over the Past 10 Years
Min: 31.03 Med: 164.21 Max: 367.29
Current: 367.29
During the past 6 years, the highestGross Margin % of Cyclezyme AB was 367.29%. The lowest was 31.03%. And the median was 164.21%.
XSAT:CYCLE's Gross Margin % is ranked better than 99.87% of 1557
companies
in the Chemicals industry
Industry Median: 23.49
vs XSAT:CYCLE: 367.29
Cyclezyme AB had a gross margin of % for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Cyclezyme AB was 0.00% per year.
Cyclezyme AB (XSAT:CYCLE) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Cyclezyme AB had a gross margin of % for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Cyclezyme AB Gross Margin % Related Terms
Cyclezyme AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for Cyclezyme AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:CYCLE vs LIN, SHW, ECL: Gross Margin % Comparison
For the Specialty Chemicals subindustry, Cyclezyme AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cyclezyme AB Gross Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Cyclezyme AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Cyclezyme AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Cyclezyme AB (XSAT:CYCLE) has a Gross Margin % of 0.00% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Cyclezyme AB and its competitors. Over the past decade, Cyclezyme AB's Gross Margin % has ranged from 31.03 to 367.29. According to the industry distribution chart, Cyclezyme AB ranks #2 out of 1557 companies in the Chemicals industry, placing it in the top 0.099999999999994%.
Is Cyclezyme AB's Gross Margin % too high?
Cyclezyme AB's current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 31.03 to a high of 367.29. Based on the distribution chart, Cyclezyme AB ranks #2 out of 1557 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Cyclezyme AB has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Cyclezyme AB's Gross Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Cyclezyme AB ranks #2 out of 1557 companies for Gross Margin %. This places Cyclezyme AB in the top 0% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 23.49. Historically, Cyclezyme AB's own Gross Margin % has ranged from 31.03 to 367.29 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Chemicals company?
The median Gross Margin % among Chemicals companies is 23.49, based on 1,557 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Cyclezyme AB and its competitors. For the Chemicals industry, the median Gross Margin % is 23.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cyclezyme AB's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyclezyme AB stock overvalued right now?
Cyclezyme AB (XSAT:CYCLE) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Cyclezyme AB's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Cyclezyme AB (XSAT:CYCLE), the current Gross Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.
8GF Score
Get the complete analysis for XSAT:CYCLE
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:CYCLE has been successfully added to your 
